MWG
JAZZ icon

Martin Worley Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Martin Worley Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$318K Hold
3,000
– – 0.16% 74
2025
Q1 		$372K Hold
3,000
– – 0.21% 67
2024
Q4 		$369K Buy
+3,000
New +$354K 0.23% 66

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Martin Worley Group's JAZZ Position: Q2 2025 in Review

Martin Worley Group held its Jazz Pharmaceuticals (JAZZ) position steady in Q2 2025 at 3,000 shares worth $318K. The position accounts for 0.16% of the portfolio, ranked #74.

Martin Worley Group first reported a position in JAZZ in Q4 2024 and has held it in 3 quarters since. The position peaked at $372K in Q1 2025. 502 funds tracked by Wall St. Rank hold JAZZ as of Q2 2025.

  • Martin Worley Group held 3,000 shares of Jazz Pharmaceuticals worth $318K as of Q2 2025.
  • Martin Worley Group left its Jazz Pharmaceuticals share count unchanged in Q2 2025.
  • Jazz Pharmaceuticals made up 0.16% of Martin Worley Group's portfolio in Q2 2025, its #74 holding.
  • Martin Worley Group first reported a position in Jazz Pharmaceuticals in Q4 2024 and has held it in 3 quarters since.
  • Martin Worley Group's Jazz Pharmaceuticals position peaked at $372K in Q1 2025.
  • 502 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2025.

Based on Martin Worley Group's 13F filing for Q2 2025, filed 12 Aug 2025.